发明名称 |
Antibody drug conjugates (ADC) that bind to 158P1D7 proteins |
摘要 |
Antibody drug conjugates (ADC's) that bind to 158P1D7 protein and variants thereof are described herein. 158P1D7 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in glioblastoma, lung cancer, bladder cancer, and breast cancer. Consequently, the ADC's of the invention provide a therapeutic composition for the treatment of cancer. |
申请公布号 |
US8968742(B2) |
申请公布日期 |
2015.03.03 |
申请号 |
US201313975214 |
申请日期 |
2013.08.23 |
申请人 |
Agensys, Inc. |
发明人 |
Morrison Robert Kendall;An Zili;Morrison Karen Jane Meyrick;Snyder Josh;Jia Xiao-Chi |
分类号 |
A61K39/395;C07K16/18;A61K47/48;A61K45/06;C07K16/30;A61K39/00 |
主分类号 |
A61K39/395 |
代理机构 |
Morrison & Foerster LLP |
代理人 |
Morrison & Foerster LLP |
主权项 |
1. An antibody drug conjugate comprising an antibody or antigen binding fragment which binds to a 158P1D7 protein, wherein the antibody or antigen binding fragment is conjugated to monomethyl auristatin E (MMAE), and wherein the antibody or fragment comprises a heavy chain variable region consisting of the amino acid sequence ranging from position 1 to position 120 of SEQ ID NO: 7 and a light chain variable consisting of the amino acid sequence ranging from position 1 to position 113 of SEQ ID NO: 8. |
地址 |
Santa Monica CA US |